InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（6 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
6
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Jakobovits Aya, 董事. Officer active across 1 company, notably Adicet Bio, Inc.. Aggregated, 8 reports have been recorded. Split: 0 buy · 6 sells. Total volume traded: €255k. Activity tracked since 12 May 2021. The latest transaction was disclosed on 5 June 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Jakobovits Aya
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
5,900 股0Common StockSEC:0000950170-24-070610:0
5,900 股0Common StockSEC:0001209191-23-033958:0
2,000 股@ US$14.000.032% mcap6.6% 占其流量Common StockSEC:0001209191-22-018158:0
2,000 股@ US$14.83190.032% mcap6.7% 占其流量Common StockSEC:0001209191-22-010952:0
6,000 股@ US$18.02080.12% mcap24.4% 占其流量Common StockSEC:0001209191-22-009417:0
1,924 股@ US$11.15656.9% 占其流量Common StockSEC:0001209191-21-041630:0
3,108 股@ US$14.052714.0% 占其流量Common StockSEC:0001209191-21-034631:0
5,000 股@ US$13.225621.5% 占其流量Common StockSEC:0001209191-21-032740:0
8 条申报中的 8 条
About Jakobovits Aya
Aya Jakobovits is a Board Member at Adicet Bio, Inc. She plays a key role in the company's governance, bringing her expertise in biotechnology and drug development. Jakobovits is involved in making strategic decisions that influence the direction of Adicet Bio. Her experience in the sector is a valuable asset to the board.
